Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 4—April 2022
Research Letter

Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine

Yusuke Miyazato, Kei YamamotoComments to Author , Gen Yamada, Shuji Kubota, Masahiro Ishikane, Masaya Sugiyama, Mikako Ueno, Akihiro Matsunaga, Tohru Miyoshi-Akiyama, Yukihito Ishizaka, and Norio Ohmagari
Author affiliations: National Center for Global Health and Medicine, Tokyo, Japan (Y. Miyazato, K. Yamamoto, G. Yamada, S. Kubota, M. Ishikane, M. Ueno, A. Matsunaga, T. Miyoshi-Akiyama, Y. Ishizaka, N. Ohmagari); National Center for Global Health and Medicine, Chiba, Japan (M. Sugiyama)

Main Article

Figure

Chest computed tomography (CT) images of a male patient in Japan who was hospitalized with multisystem inflammatory syndrome. A) CT performed at hospital admission revealed infiltration in bilateral lower lobes. B) Chest CT performed 1 month after discharge revealed that most of these lesions had resolved.

Figure. Chest computed tomography (CT) images of a male patient in Japan who was hospitalized with multisystem inflammatory syndrome. A) CT performed at hospital admission revealed infiltration in bilateral lower lobes. B) Chest CT performed 1 month after discharge revealed that most of these lesions had resolved.

Main Article

Page created: February 11, 2022
Page updated: March 19, 2022
Page reviewed: March 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external